JQJO — Latest news · Page 140

Avengers Endgame has reclaimed its position as the highest-grossing film in global box office history following a strategic theatrical re-release by The Walt Disney Company. The 2019 superhero feature collected 4.4 million dollars domestically and 14.4 million dollars internationally during its second weekend run. This latest push elevated its cumulative worldwide earnings to 2.9255 billion dollars, narrowly surpassing the 2.9237 billion dollar total amassed by James Cameron's Avatar. The re-issue campaign was intentionally scheduled by studio executives to build consumer momentum and anticipation ahead of the upcoming theatrical launch of Avengers Doomsday. Avatar originally debuted in 2009 through Twentieth Century Fox and held the global crown for a decade before Endgame initially overtook it in 2019. Avatar subsequently reclaimed the top position in 2021 through an international re-release ahead of the rollout of its sequel, Avatar The Way of Water. Industry analysts note that contemporary studio strategies increasingly rely on coordinated catalog re-issues.

Philadelphia Eagles running back Saquon Barkley was ruled out for the remainder of Sunday's game against the Los Angeles Rams after sustaining a right hamstring injury in the first quarter. Barkley was hurt following a six-yard run, prompting medical evaluation inside a sideline tent before he walked to the locker room. The team officially ruled him out during the second quarter while holding a thirteen to three lead. Barkley entered the matchup having rushed for one hundred seventy-four yards across the first three games of the season. His early departure compounds an already severe roster challenge for the Eagles, who entered the contest playing without six regular starters, including wide receiver DeVonta Smith and offensive lineman Lane Johnson. The loss of a primary offensive weapon places immediate strain on backup running backs and remaining healthy playmakers as Philadelphia navigates a heavily depleted lineup during a critical early-season matchup.

Recent health analysis data indicates that shingles diagnoses are declining significantly among individuals aged 34 and younger in the United States. Researchers examined electronic health records from over 85 million patients between 2019 and 2026, finding that younger generations eligible for the chickenpox vaccine as children experience lower rates of the painful blistering condition. Specifically, shingles cases among younger adults more than halved during this period. The Food and Drug Administration approved the varicella zoster vaccine in 1995, leading to widespread childhood immunization and a dramatic drop in chickenpox infections nationwide. Conversely, researchers observed that shingles rates continue to climb among older adults who contracted natural chickenpox infections in childhood, potentially due to reduced exposure to natural viral boosters from infected children. While shingles remains rare in populations under 50, health officials note that the findings point toward substantial long-term benefits from early childhood vaccination programs.